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Pre-Travel Medical Preparation of Business and
Occupational Travelers
An Analysis of the Global TravEpiNet Consortium, 2009 to 2012
Nomana M. Khan, MPH, Emily S. Jentes, PhD, Clive Brown, MBBS, Pauline Han, MA, Sowmya R. Rao, PhD,
Phyllis Kozarsky, MD, Stefan H.F. Hagmann, MD, Regina C. LaRocque, MD, and Edward T. Ryan, MD,
Global TravEpiNet Consortium (GTEN)
Objectives: The aim of the study was to understand more about pre-
travel preparations and itineraries of business and occupational travelers.
Methods: De-identified data from 18 Global TravEpiNet clinics from
January 2009 to December 2012were analyzed.Results: Of 23,534 travelers,
61% were non-occupational and 39% occupational. Business travelers were
more likely to be men, had short times to departure and shorter trip durations,
and commonly refused influenza, meningococcal, and hepatitis B vaccines.
Most business travelers indicated that employers suggested the pre-travel
health consultation, whereas non-occupational travelers sought consultations
because of travel health concerns. Conclusions: Sub-groups of occupational
travelers have characteristic profiles, with business travelers being particularly
distinct. Employers play a role in encouraging business travelers to seek pre-
travel consultations. Such consultations, even if scheduled immediately before
travel, can identify vaccination gaps and increase coverage.
I n 2014, 1.1 billion travelers crossed international borders.
1 A
2012 report outlined that 18% of US residents visiting overseas
destinations traveled for business purposes, and each traveler had a
median of three international trips in the past 12 months and a
median stay of 8 nights per trip.2 Business travelers may face
different health risks than leisure travelers, including occupational
exposures and increased levels of stress due to their work sched-
ules.3,4 In addition, business travelers are increasingly visiting
developing countries.4,5 Research suggests that the risk of illness
increases with greater differences in climate and culture between the
country of origin and the destination country.6 Further, occupational
travel may contribute to the importation of disease to the traveler’s
home workplace and larger community; such importations often
require costly workplace and public health responses. Many infec-
tions associated with occupational travel can be prevented by simple
preventative measures, such as vaccines, medications, and health
advice.
Pre-travel health consultations are an opportunity to assess and
mitigate the risk of illness and injury for travelers. Such evaluations
review destination-specific epidemiology of illness and injury, risk
factors related to the itinerary and the traveler’s medical history,
severity and treatability of diseases if acquired, and availability and
efficacy of chemoprophylaxis or vaccination.7 To understand more
about pre-travel preparations and trip characteristics of business and
other occupational travelers, we analyzed the pre-travel health con-
sultations of travelers seeking care in Global TravEpiNet (GTEN), a
large consortium of US clinics that provides pre-travel health con-
sultations.8 The purpose of this article is two-fold: (1) to describe
occupational travelers by category of self-selection (business, provid-
ing medical care, providing non-medical service work, participating
in missionary work, taking part in research/education) and (2) to
compare business travelers with leisure travelers and with those who
were visiting friends and relatives (VFRs).
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METHODS
GTEN is a consortium of US medical practices that includes
academic institutions, health maintenance organizations, pharmacy-
based clinics, and public health clinics that provide pre-travel health
consultations to international travelers; it is described in detail
elsewhere.8 In brief, GTEN collects data from pre-travel consul-
tations of international travelers visiting consortium sites. This data
collection began in January 2009 and is ongoing; data collected
from 18 clinics from January 2009 through December 2012 were
used for this analysis. Human Subjects Advisors at each participat-
ing site reviewed and approved or exempted the collection and
subsequent analyses of the de-identified data.
GTEN data are collected using a secure online tool, which
creates an individual traveler medical note and provides guidance to
the health care provider on the latest recommendations published by
the US Centers for Disease Control and Prevention (CDC). Trav-
elers self-reported, into the tool, their sex, age, country of birth,
purpose of travel, destinations, itinerary-related details, reasons for
seeking the pre-travel consultation, medications, and medical con-
ditions. Anyone born in the 50 US states or US Virgin Islands was
considered ‘‘US born.’’ Health care providers verified the infor-
mation provided by the traveler and also recorded the patient’s
previous vaccination status, vaccinations and chemoprophylaxis
that were recommended, and health education that was provided.
If a recommended vaccination was not given, the provider was
prompted to give a reason for non-vaccination, including the
following: vaccine was not available, insufficient time for com-
pletion before departure, patient declined, referral to primary care
provider for administration, or medical contraindication. For rabies
vaccine, clinicians were prompted to provide a reason if the vaccine
was not recommended for those traveling for longer than 1 month
(defined as 28 days).
We evaluated the proportion of GTEN travelers vaccinated
for the following diseases: measles, mumps, rubella (MMR);
hepatitis B; influenza; varicella; tetanus; hepatitis A; yellow fever
(YF); typhoid; rabies; meningococcal; polio; and Japanese ence-
phalitis (JE). For this analysis, MMR, influenza, varicella and
tetanus vaccines were defined as generally recommended for all
travelers before departure if they were not already immune. The
proportion of travelers vaccinated for hepatitis A, hepatitis B ,and
typhoid was assessed for specific groups going to endemic countries
(high- and intermediate-risk countries for hepatitis A and B; high-
risk countries for typhoid) based on the most current CDC recom-
mendations available at the time of the consultation.9,10 The pro-
portion of travelers vaccinated for polio, rabies, meningococcal
disease, JE, and YF was assessed for specific groups of at-risk
travelers who met criteria (eg, destination country with risk, season
with risk, duration of stay, or indicated for the itinerary) for
recommended vaccination; a more extensive description of travelers
who were considered at risk is available elsewhere.11 For all
vaccines, if the clinician indicated existing immunity or if the
traveler received at least the first dose of a vaccine series at the
pre-travel consultation, the traveler was considered, for this
analysis, vaccinated for that disease. To analyze reasons for non-
vaccination, we excluded those who were previously immune, were
vaccinated at the clinic visit, or for whom information was
not known.
To accurately evaluate the trip duration and activities, only
travelers with one purpose of travel and one itinerary were included.
Travelers younger than 18 years were excluded from all analyses
because they are less likely to travel for business or other occu-
pational reasons, and legally do not make the primary decisions
regarding their health care.
Travelers self-defined their purpose of travel; those who
selected business as their purpose of travel were classified as
business travelers. We also considered the following purposes of
travel to be occupational: providing medical care, providing non-
medical service work, participating in missionary work, and taking
part in research/education. Non-occupational travelers were classi-
fied as those traveling for leisure or those visiting friends and
relatives. In accordance with the CDC definition, those VFRs were
defined as those who selected their reason of travel as ‘‘returning to
region of origin of self or family to visit friends and relatives’’ and
who were visiting at least one United Nations Human Development
Index low- or low–middle-income country.12 Other purposes of
travel collected by the GTEN tool, including military deployment,
receiving medical care, adoption, adventure, attending large gather-
ings or events, and other, were excluded from the analysis.
We conducted two analyses: (1) a general description of
business and all other occupational travelers in GTEN, and (2) a
comparison of business travelers to those traveling for non-occu-
pational purposes (leisure and VFR). We analyzed all data by using
SAS 9.2 (SAS Institute, Cary, NC). For bivariate analyses of
categorical variables between business travelers and leisure (or
VFR) travelers, random intercept models were used with clinic
site as the random effect to account for possible between-clinic
variation and Morel, Bokossa, and Neerchal adjustment to correct
for the small number of sites.13 Kruskal-Wallis tests were used for
comparative analyses of continuous variables. A two-sided P val-
ue< 0.05 was considered statistically significant.
RESULTS
Of 39,589 total GTEN travelers, 23,534 (59%) met our
inclusion criteria. Of these travelers, 9248 (39%) were occupational
(including business travelers) and 14,286 (61%) were non-occu-
pational. Of the 9248 occupational travelers, 4174 (45%) were
business travelers, 1714 (19%) were performing research/education,
1249 (14%) were participating in missionary work, 1215 (13%)
were providing non-medical service work, and 896 (10%) were
providing medical care (Table 1). Among the non-occupational
travelers, 13,095 (92%) were leisure and 1191 (8%) were VFR
travelers. (Table 2)
Description of Business and Other Occupational
Travelers
Most (more than 59%) of the occupational travelers, except
for business (39%), were women (Table 1). Among all occupational
travelers, missionaries and non-medical service workers sought pre-
travel care further in advance of their departure date, with median
times to departure of 33 and 32 days, respectively. Business
travelers had the shortest time to departure (median 15 days). Most
business travelers (52%) indicated that their employer suggested
they make the pre-travel health appointment, but most other occu-
pational travelers reported that being concerned about health issues
related to travel had prompted them to make a pre-travel
health appointment.
India was the top destination both for business (24%)
and research/education (9%) travelers. China (7%) and South
Africa (4%) were the other two most commonly visited desti-
nations for business travelers. Although Haiti was selected by
most of those providing medical care (20%) and missionaries
(15%), Honduras was most common for non-medical service
workers (14%). (It should be noted that a large earthquake
occurred in Haiti in 2010 during the data collection period of
this current study.)
Both business travelers and those providing medical care had
the shortest trips (both medians 10 days). Most occupational
travelers, including business travelers, planned on staying at hotels,
except non-medical service workers who reported dorms/hostels as
the most common planned accommodation.
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Comparison of Business Travelers to Non-
Occupational Travelers
Demographic and Travel Characteristics
More business travelers than leisure or VFR travelers were
men (61% vs 43%; P< 0.0001) (Table 2). Business travelers had
less time to departure than did leisure travelers (15 days vs 29 days;
P< 0.0001) but were similar to VFR travelers (15 days vs 14 days;
P¼ 0.05 (Table 2). For leisure and VFR travelers, being concerned
about health issues related to travel (40% and 49%, respectively)
was the most common reason for the pre-travel consultation. For
business travelers, 25% reported being concerned about health
issues related to travel as their reason for seeking pre-travel
health consultation.
Business travelers traveled for shorter periods of time than
did leisure travelers (10 days vs 14 days; P< 0.0001) or VFR
travelers (10 days vs 30 days; P< 0.0001). Eighty-two percent of
business travelers and 60% of leisure travelers chose a hotel as the
most common type of accommodation, whereas more than 80% of
VFR travelers reported staying in a home with relatives. Of note,
VFR travelers had different top destination countries (Ghana,
Ethiopia, and Nigeria) compared with both occupational and
non-occupational groups. More business travelers reported travel
to only urban areas than did leisure (67% vs 24%; P< 0.0001) and
VFR (67% vs 45%; P< 0.0001) travelers (data not shown).
Use of Vaccines and Pre-Existing Immunity
The proportion of business travelers with immunity (those
with pre-existing immunity or vaccinated [if indicated] at the pre-
travel visit) was at least 90% for tetanus, hepatitis A, YF, and
typhoid (Fig. 1). For leisure and VFR travelers, the proportion with
immunity was at least 80% for tetanus, YF, and typhoid. Clinicians
reported that 78% of business travelers had pre-existing immunity
for MMR (28% of those who had pre-existing immunity were born
before 1957) and an additional 11% received vaccination at the pre-
travel consultation. Thirty-eight percent of business travelers had
pre-existing immunity to influenza, and an additional of 29%
received vaccinations with the pre-travel visit. Only 60% of business
travelers were vaccinated or considered immune to hepatitis B after
the pre-travel consultation. At the pre-travel consultation, 40% of
VFR travelers, 37% of business travelers, and 27% of leisure
travelers received meningococcal vaccine. At the time of the visit,
22% of business, 18% of leisure and 17% of VFR travelers had
TABLE 1. Demographic and Travel Characteristics of Occupational Travelers Seen for Pre-Travel Health Consultation in the
Global TravEpiNet Consortium (n¼9,248)
Business
Research/
Education Missionary
Non-Medical
Service Work
Providing
Medical Care
Total (n, row %) 4,174 (45) 1,714 (19) 1,249 (14) 1,215 (13) 896 (10)
Age (median, range) 41 (18–86) 24 (18–85) 38 (18–80) 22 (18–77) 30 (18–77)
Gender (column %)
Women 1,608 (39) 1082 (63) 733 (59) 804 (66) 593 (66)
Men 2,566 (61) 632 (37) 516 (41) 411 (34) 303 (34)
Country of birth (column %)
United States 3595 (86) 1514 (88) 1165 (93) 1113 (92) 788 (88)
Non-US 579 (14) 200 (12) 84 (7) 102 (8) 108 (12)
Number of destination countries (column %)
1 3344 (80) 1432 (84) 1167 (93) 1132 (93) 849 (95)
>2 828 (20) 282 (16) 81 (7) 83 (7) 47 (5)
Top three destinations
India 1,513 (24) India 208 (9) Haiti 216 (15) Honduras 180 (14) Haiti 193 (20)
China 419 (7) China 150 (7) Kenya 127 (9) Haiti 139 (11) Honduras 86 (9)
South Africa 238 (4) Ghana 147 (6) Honduras 62 (4) Ghana 79 (6) Ghana 83 (9)
Type of accommodation (column %)y,z
Hotel 3,765 (82) 934 (43) 549 (35) 423 (28) 424 (40)
Home stay with relatives 33 (1) 23 (1) 12 (1) 13 (1) 3 (<1)
Dormitory or hostel 183 (4) 639 (29) 353 (23) 521 (34) 345 (32)
Home stay with non- relatives 145 (3) 367 (17) 254 (16) 234 (15) 87 (8)
Personal home/apartments 248 (5) 171(8) 193 (12) 116 (8) 64 (6)
Other§ 200 (5) 60 (2) 197 (14) 215 (14) 148 (15)
Reason for visiting clinic (column %)y,z
Concerned about health issues related to travel 927 (25) 479 (32) 457 (39) 380 (35) 254 (32)
Primary care provider referred 494 (13) 228 (15) 209 (18) 110 (10) 63 (8)
Family member/friend suggested 203 (5) 210 (14) 267 (23) 158 (14) 57 (7)
Employer suggested to make an appointment 1938 (52) 253 (17) 65 (6) 60 (5) 156 (20)
Read information on internet 281 (8) 169 (11) 144 (12) 77 (7) 66 (8)
Travel agent suggested 81 (2) 72 (5) 60 (5) 57 (5) 23 (3)
Saw a public health announcement 32 (1) 19 (1) 4 (<1) 4 (<1) 5 (1)
Median time to departure in days (range)jj 15 (0–460) 26 (0–468) 33 (0–366) 32 (0–404) 25 (0–782)
Median duration of travel in days (range) 10 (0–1655) 24 (4–2011) 11 (1–1900) 13 (0–1620) 10 (2–2190)
US born¼ born in the 50 US states or US Virgin Islands.
yPercentages may not add up to 100% due to rounding.
zMultiple responses possible.
§‘‘Other’’ includes camp, cruise, lodge, boat, tree houses, cabin, and bed and breakfasts.
jjTime to departure¼ (departure date clinic visit date).
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immunity to JE. Few business, leisure, or VFR travelers were
considered immune to or vaccinated against rabies.
Vaccine Refusal
Figure 2A and B outlines the reasons for non-vaccination
among business, VFR, and leisure travelers. When compared with
leisure and business travelers, a higher percentage of VFR travelers
declined vaccines. Among those business travelers who were
recommended the specific vaccine, 49% declined influenza
vaccine, 41% MMR vaccine, 32% meningococcal vaccine, 19%
hepatitis B vaccine, 15% rabies vaccine, and 12% JE vaccine.
Thirty six percent of leisure and 69%ofVFR travelers also declined
MMR vaccine. Clinicians reported that influenza vaccine was
unavailable for 22% of business, 19% of VFRs, and 21% of leisure
travelers. For business travelers, clinicians reported insufficient
time to complete the vaccine series for JE (23%), hepatitis A (11%),
hepatitis B (10%), and rabies (10%). Based on current CDC
criteria, clinicians considered hepatitis B, rabies, meningitis, polio,
or JE vaccines not to be indicated for more than half of business or
leisure travelers.
Use of Anti-Malarial Medication
For those traveling to a country where malaria was a risk
throughout, 91% of business, 90% of leisure, and 88% of VFR
travelers were prescribed an anti-malarial medication. Of the 291
travelers whowere not prescribed anti-malarial medication, 19 (7%)
declined the medication and 17 (6%) had existing prescription from
their primary care provider; there was no additional information for
the other 255 (87%) travelers. Mefloquine was the most common
prescription for VFR travelers (49%), and atovaquone/proguanil
was most common among business (73%) and leisure (76%) trav-
elers.
DISCUSSION
Our analysis shows that business travelers differ both from
other occupational travelers and non-occupational travelers (leisure
and VFRs). Business travelers are predominantly men, generally
older, and seek pre-travel consultations largely on the advice of their
employer. Compared with other travelers, business travelers receive
pre-travel health care closer to their travel date, plan on hotel stays
in urban areas, and travel for shorter durations. Although some
TABLE 2. Comparison of Demographic and Travel Characteristics of Business, Leisure, and Those Visiting Friends and
Relatives (VFR) Travelers Seen for Pre-Travel Health Consultation in the Global TravEpiNet Consortium (n¼18,460)
Business Leisure VFR
Total (n, row %) 4,174 (23) 13,095 (71) 1,191 (6)
Age in years (median, range) 41 (18–86) 46 (18–92) 41 (18–93)
Gender (column %)y
Women 1,608 (39) 7,412 (57) 684 (57)
Men 2,566 (61) 5,683 (43) 507 (43)
Country of birth (column %)z,§
United States 3,595 (86) 11,894 (91) 55 (5)
Non-US 579 (14) 1,201 (9) 1,136 (95)
Number of destination countries (column %)
1 3,344 (80) 8,710 (67) 1,140 (96)
>2 830 (20) 4,385 (33) 51 (4)
Top three destinations (column %)
India 1,513 (24) South Africa 1,550 (7) Ghana 167 (14)
China 419 (7) India 1,472 (7) Ethiopia 144 (12)
South Africa 238 (4) Thailand 1,326 (6) Nigeria 102 (8)
Type of accommodation (column %)jj,{
Hotel 3,765 (82) 11,140 (60) 152 (11)
Home stay with relatives 33 (1) 992 (5) 1,110 (83)
Dormitory or hostel 183 (4) 1,187 (6) 7 (1)
Home stay with non- relatives 145 (3) 1,341 (7) 52 (4)
Personal home/apartments 248 (5) 313 (2) 6 (<1)
Other 200 (5) 4,034 (21) 15 (2)
Reason for visiting clinic (column %)jj,{
Concerned about health issues related to travel 927 (25) 4,428 (40) 526 (49)
Primary care provider referred 494 (13) 2,223 (20) 170 (16)
Family member or friend suggested 203 (5) 1,817 (16) 158 (15)
Employer suggested to make an appointment 1,938 (52) 105 (1) 13 (1)
Read information on internet 281 (8) 1,479 (13) 60 (6)
Travel agent suggested to make an appointment 81 (2) 750 (7) 18 (2)
Saw a public health announcement 32 (1) 107 (1) 7 (1)
Median time to departure in days (range)#, 15 (0–460) 29 (0–564) 14 (0–383)
Median duration of travel in daysyy 10 (0–1655) 14 (0–1421) 30 (0–999)
Business vs leisure P< 0.0001; business vs VFR P¼ 0.9956 (Kruskal-Wallis).
yBusiness vs leisure P< 0.0001; business vs VFR P< 0.0001 (random intercept models).
zUS born¼ born in the 50 US states or US Virgin Islands.
§Business vs leisure P< 0.0001 (random intercept models). VFRs were excluded from this analysis as they were defined by country of birth.
jjPercentages may not add up to 100% due to rounding.
{Multiple responses possible.
#Time to departure¼ (departure date clinic visit date).
Business vs leisure P< 0.0001; business vs VFR P¼ 0.05 (Kruskal-Wallis).
yyBusiness vs leisure P< 0.0001; business vs VFR P< 0.0001 (Kruskal-Wallis).
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business travelers received influenza (21%), meningococcal (37%),
and hepatitis B (20%) vaccines with the visit, many business
travelers (49%, 32%, and 19%, respectively) declined to
receive them.
The demographic profiles of business and occupational
travelers described here are similar to those found in other studies.
In a study by Hill, and consistent with our findings, business
travelers were younger than leisure travelers and older than those
FIGURE 2. Reasons for not vaccinating
in the pre-travel visit for business,
leisure and VFR travelers in Global Trav-
EpiNet, by purpose of travel. HA,
hepatitis A; HB, hepatitis B; I, influenza;
JE, Japanese encephalitis; M, meningo-
coccal; MMR, measles, mumps,
rubella; P, polio; R, rabies; Td, typhoid;
Tt, tetanus; V, varicella; YF, yellow fever.
Percentages may not add up to 100%
due to rounding errors.
FIGURE 1. Pre-existing immunity and
vaccination of travelers in Global
TravEpiNet, by purpose of travel. HA,
hepatitis A; HB, hepatitis B; I, influenza;
JE, Japanese encephalitis; M, menin-
gococcal; MMR, measles, mumps,
rubella; P, polio; R, rabies; Tt, tetanus
(includes Td and Tdap); Ty, typhoid; V,
varicella; YF, yellow fever. Percentages
may not add up to 100% due to round-
ing errors.
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traveling for education or study.14 Non-medical service (median 22
years) and research/education travelers (median 24 years) in our
analysis were the youngest of all occupational travelers. Like our
investigation, other studies have also found that business travelers
are predominantly men.14,15
Within the occupational category, missionary and non-
medical service workers sought pre-travel advice at least a month
ahead of their travel date. In contrast, only half of business travelers
sought pre-travel advice within 2 weeks of travel; a finding also
noted in previous research.16 The need for business travel can occur
suddenly, leading to shorter preparation time17; however, business
travelers may know about their trip further in advance than the
timing of their pre-travel health appointment may indicate. In fact,
the US Department of Commerce Office of Trade and Tourism
found that people reporting travel for business and convention
purposes planned their trip a median of 30 days in advance, and
airline reservations were made a median of 21 days in advance.2 It is
not known from our analysis how far in advance travelers planned
their itineraries or if there was a delay in seeking pre-travel health
consultations after plans were finalized.
Seeking pre-travel care within 2 weeks of travel makes
travelers less likely to complete or maximally benefit from recom-
mended vaccine regimens; starting malaria chemoprophylaxis or
filling other recommended prescriptions may also be compromised.
In support of this, we found that GTEN clinicians reported insuffi-
cient time for some business travelers to complete the series of JE,
hepatitis A, hepatitis B, and rabies vaccines. Travelers would benefit
from having their pre-travel health consultations as soon as travel is
booked to complete or follow accelerated vaccine schedules. Many
companies make pre-travel health consultations mandatory during
the airline ticket-issuing process.16 Alternatively, if general business
travel is anticipated, travelers should consider pre-emptive vacci-
nation to ensure full coverage before last-minute travel.17 Although
GTEN does not collect information on risk perception, last minute
travelers believe that their disease risk is lower.18 Travelers should
also consider the placement of their international worksites; because
many facilities are located outside of cities, travelers and clinicians
need to consider both urban and peri-urban exposures to mosqui-
toes, and thus mosquito-borne illnesses. Pre-travel health consul-
tations sought well in advance ensures that proper risk assessments
and guidance can be acted upon for each traveler’s destination.
We found the median duration of travel for business travelers
was 10 days, which was similar to US Department of Commerce
Office of Trade and Tourism’s finding of 8 days.2 Other occu-
pational travelers with shorter durations of stay included those
providing medical care (10 days) and missionaries (11 days). Both
leisure travelers and VFRs had significantly longer stays of 14 and
30 days, respectively. All travelers, but especially short-term trav-
elers, may not fully recognize the illness and injury risks associated
with international travel.4,16 Business travelers often do not consider
unexpected risks, such as those associated with unanticipated
medical treatment or casual sexual activity.19 In addition, business
travelers often travel multiple times a year.2 We did not collect
information on the number of trips taken each year by the travelers;
however, each trip can contribute to the risk of a travel-related
illness. Clinicians seeing travelers should consider this cumulative
risk assessment when advising business travelers and consider
interventions, such as vaccinations, an investment for future trips.7
The pre-travel health consultations described here increased
the vaccination coverage for all of the vaccines and provided malaria
prescriptions for most travelers, although several gaps still remain.
Of particular interest, many business (49%), leisure (44%), and VFR
(61%) travelers declined influenza vaccine. Despite high morbidity
and mortality rates associated with influenza, a significant pro-
portion of the US population chooses not to get vaccinated against
the disease.20 According to CDC estimates, only 42.8% of all people
older than 2 years, and 48.4% of people with high-risk indications
between the ages of 18 and 64 years were vaccinated against
influenza in the 2010 to 2011 season.21 A GeoSentinel analysis
of returned ill travelers found that business travel was associated
with influenza.22 Further, a study of Swiss business travelers found
that only 27% had their annual influenza vaccination.23 In addition
to reducing the risk of decreased productivity due to illness,
increasing influenza vaccination coverage in travelers can prevent
the translocation of disease back to coworkers in the United States.
It is beneficial for employers to emphasize the importance of
vaccination, especially influenza vaccine.
In our analysis, more than half of the business travelers were
referred to the clinics by their employers. Although we were unable
to elucidate whether travelers in our data set have employer-
sponsored insurance or the employer was paying directly for the
appointment and/or medications and vaccines, employers played a
role in directing the travelers to the clinics. It is the traveler’s
responsibility to obtain pre-travel health advice, but employers also
have a responsibility to ensure the well-being of their employees
during and after business-related travel. This employer responsi-
bility is not only to the travelers themselves, but also to employees
who remain behind in the United States. Infections and injuries in
business travelers not only negatively affect the travelers themselves
but also have negative consequences for the business. Illness may
disrupt business activities during or after travel, cause loss of time
and productivity, and increase medical costs.24 One study found
higher rates of medical claims for almost all diseases categories
after international travel by business travelers compared with their
non-traveling colleagues; many claims were related to infectious
diseases.25 History has shown that diseases such as SARS, hepatitis
A, measles, and tuberculosis have all been transmitted by individ-
uals traveling for business and other occupational travelers26–30;
and infections such as these may be transmitted to non-traveling
employees or the traveler’s community. It should be noted that
occupational travelers and especially business travelers are more
likely to visit Asia than VFRs or leisure travelers so the groups have
different destination patterns and infectious disease risks. Although
employers may shoulder the costs of the pre-travel health consul-
tations, the costs of ill employees may be higher.31 To prevent illness
in travelers and the translocation of disease to employees in the
United States, employers can increase the proportion of travelers
seeking timely pre-travel care by developing corporate health
strategies, providing travel-related health education to improve risk
perceptions, planning trips ahead of time when possible, and
allowing time for health consultations for travelers with short time
to departures.
Limitations
Our investigation has some limitations. GTEN data, although
geographically distributed, may not be representative of the general
traveling population, or business travelers in particular; however,
our findings are consistent with those of other studies. We focused
only on travelers who listed a single purpose of travel and therefore
did not explore further those who listed multiple purposes of travel.
In addition, purpose of travel was self-selected by travelers, and we
focused specifically on those who chose business or other occu-
pational or service as their purpose for travel. There was no
additional information, such as whether the traveler received com-
pensation, to support that these travelers were unquestionably
occupational or non-occupational. We also recognize that our
category of occupational travelers includes a number of sub-groups,
which is the reason that we performed sub-analyses. Finally,
because sub-national destination data were not available, we could
only assess the suitability of malaria chemoprophylaxis recommen-
dations in those traveling to countries where malaria was a risk
throughout. Further, GTEN does not systematically collect
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information on patients who did not receive a prescription for
malaria chemoprophylaxis; however, analysis of text fields provided
limited information. Despite these limitations, our study is, to our
knowledge, the largest analysis of detailed pre-travel health con-
sultations prior to business and occupational-related travel, includ-
ing data on over 9000 occupational travelers. In this era of large
multinational corporations and outsourcing, our findings are of
interest to businesses, and particularly to health care workers
charged with caring for individuals whose work assignment
involves international travel.
CONCLUSIONS
Business and occupational travel has repetitively been associ-
ated with illness not only among travelers themselves, but has also
led to the importation of infectious diseases into home and work
communities, and these importations often require costly work and
public health responses. Business travelers have a distinct profile
when compared with other occupational and non-occupational
travelers. Employers play a role in encouraging business travelers
to seek pre-travel health consultations. Such consultations, even if
scheduled immediately before travel, can be an opportunity to
identify vaccination gaps and to increase coverage to lessen the
likelihood of illness among travelers and importation of pathogens
into home and work communities.
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